Is CELZ or CGEM more undervalued in 2026?

CirclFi compares Creative Medical Technology Hol (CELZ) and Cullinan Therapeutics, Inc. (CGEM) using 13 institutional-grade valuation models. CELZ has a Quality of Company score of 5.1/10 while CGEM scores 4.4/10.

Which is a better buy — CELZ or CGEM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CELZ and CGEM valuations compare?

CELZ at $2.25 and CGEM at $15.36 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CELZ vs CGEM Valuation Comparison 2026 — Intrinsic Value Analysis

CELZ

Biotechnology

Creative Medical Technology Hol

Quality

5.1

out of 10

Value Trap

WARN

Price

$2.25

Last close

Models

11/13

Active

CGEM

Biotechnology

Cullinan Therapeutics, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$15.36

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	CELZ Fair Value	CELZ Upside	CGEM Fair Value	CGEM Upside
Bayesian DCF	Intrinsic	$1.45	-35.7%	$4.78	-68.9%
Earnings Power Value	Intrinsic	$1.63	-27.3%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.10	-95.8%	$1.71	-88.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CELZ vs CGEM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CELZ vs CGEM — Which Stock Is More Undervalued?

CELZ scores higher with a 5.1/10 quality rating vs CGEM's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Creative Medical Technology Hol (CELZ) and Cullinan Therapeutics, Inc. (CGEM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CELZ currently trades at $2.25 with a QOC of 5.1/10, while CGEM trades at $15.36 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).